Winton Group Ltd

SEC CIK: 0001612063
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

BCRX holding history

Biocryst Pharmaceuticals Inc in every 13F filed by Winton Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BCRX overview All 13F holders of BCRX Full Q2 2026 holdings

Shares (Q2 2026): 255,600
Value: $2.56M
% of portfolio: 0.1%
Quarters held: 3; Since Q4 2025

Holdings of BCRX by Winton Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	255,600	$2.56M	0.1%	+202,384+380.3%	Added	Holders
Q1 2026	53,216	$506.6K	<0.1%	+37,616+241.1%	Added	Holders
Q4 2025	15,600	$121.7K	<0.1%	+15,600	New	Holders